Bibliografia
1 - Gianfrancesco Valsè Pantellini (1997) Il cofattore K, Cinquant’anni di ricerca e terapia contro i tumori, Ed. Andromeda)
2 - Hughes F, Bortner C, Purdy G, Cidlowski J (1997): Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J. Biol Chem., (272), pp.30567-30576
3 - Hughes FM Jr, Cidlowski JA. (1999) Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv. Enzyme Regul., 39, pp.157-171
4 - Montague J, Bortner C, Hughes F, Cidlowski J (1999) A necessary role for reduced intracellular potassium during the DNA degradation phase of apoptosis. Steroids, 64, pp.563-569
5 - Paoli G: La via del sale, Scienza e Conoscenza, 2007, 21:60-65
6 - Paoli G: Il metodo Pantellini, Scienza e Conoscenza, 2013, 46:16-23.
7 - J Environ Pathol Toxicol Oncol. 1996; 15(2-4):65-73. Potassium, sodium, and cancer: a review. Jansson B., Department of Biomathematics, University of Texas
8 - Journal of Experimental Therapeutics & Oncology . 2004, Vol. 4 Issue 2, p161-166. 6p.Targeting K+ channels for cancer therapy.Conti, Matteo
9 - The journal cell biology2014 Archive,21 July» 206 (2): 151 ReviewTargeting potassium channels in cancer.Xi Huang, Lily Yeh Jan
10 - Met Ions Life Sci. 2016;16:585-601. doi: 10.1007/978-3-319-21756-7_16. Sodium and Potassium Relating to Parkinson's Disease and Traumatic Brain Injury. Ha Y,Jeong JA,Kim Y,Churchill DG.
11 - “Cancer Cell International” 2011, 11:30. Potassium bicarbonato and D-ribose effects on A72 canine and HTB-126 human cancer cell line proliferation in vitro. Croci S, Bruni L, Bussolanti S, Castaldo M, Dondi M: Dipartimento di Neuroscienze, Università di Parma
12 - “Anticancer Research” 2011 Nov; 31(11):3973-6 “Beckwith-wiedemann syndrome: potassium ascorbate with ribose therapy in a syndrome with high neoplastic risk.” ; Anichini C, Lo Rizzo C, Longini M, Paoli G, DI Bartolo RM, Proietti F, Buonocore G. Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena.
13 - “Disease Markers” 2012 Sep 6; “Antioxidant effects of potassium ascorbate with ribose therapy in a case with Prader Willi Syndrome.”; Anichini C, Lotti F, Longini M, Proietti F, Felici And C, Buonocore G. Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena, Siena, Italy.
14 - “Anticancer Research” 2013 Feb; 33(2):691-5.: “Antioxidant effects of potassium ascorbate with ribose in Costello syndrome.”; Anichini C, Lotti F, Pietrini A, Lo Rizzo C, Longini M, Proietti F, Felici C, Buonocore G. Department of Pediatrics, Obstetrics and Reproductive Medicine, University of Siena.
15 - Croci S, Pedrazzi G, Paoli G, Monetti D, Bronzetti G, Ortalli I (2001). Potassium ascorbate as protective agent in oxidation of red cells.Abstract of the International Conference on Antioxidants in Cancer Prevention and Therapy, Athens (Greece) :1571-1572
16- Kevin J. Lenton, Hélène Therriault, Tamàs Fülöp, Hélène Payette, and J. Richard Wagner. Glutathione and ascorbateare negatively correlated with oxidative DNA damage in human lymphocytes Carcinogenesis, Apr 1999; 20: 607 – 613.